Bone marrow mesenchymal stem cell-derived exosomes ameliorate intervertebral disc degeneration by regulating HMGB1 acetylation via SIRT6
Biochemical and Biophysical Research Communications · 2026-05 · 814 · 153648
DOI: 10.1016/j.bbrc.2026.153648 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biochemical and Biophysical Research Communications, 2026-05. Verfasst von Hongshen Wang und 8 weiteren Autor:innen. Beteiligte Einrichtung: The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, 510120, China; Guangdong Provincial Hospital of Chi…. Hauptthemen laut MEDLINE: HMGB1 Protein, Sirtuins, Exosomes, Mesenchymal Stem Cells. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 77 Literaturangaben. Gefördert von: Department of Science and Technology of Guangdong Province, Department of Education of Guangdong Province, National Natural Science Foundation of China.
Abstract (Originalsprache)
BACKGROUND: Intervertebral disc degeneration (IVDD) is a leading cause of low back and leg pain and is primarily driven by inflammation-induced apoptosis of nucleus pulposus (NP) cells. Bone marrow mesenchymal stem cell-derived exosomes (BMSC-exos) have shown strong therapeutic potential for degenerative diseases. Sirtuin 6 (SIRT6), a key regulator of aging and inflammation, has been closely associated with IVDD progression. Therefore, we hypothesized that BMSC-exos might alleviate IVDD by promoting SIRT6-mediated deacetylation of high mobility group box 1 (HMGB1), thereby suppressing inflammation. METHODS: In the present study, BMSC-exos were isolated from BMSCs and characterized using transmission electron microscopy (TEM), nanoparticle tracking analysis (NTA), and Western blot analysis. The mechanisms by which BMSC-exos regulate the SIRT6/HMGB1/Toll-like receptor 4 (TLR4)/nuclear factor kappa-B (NF-κB) signaling pathway were investigated using Cell Counting Kit-8 (CCK-8) assay, reverse transcription-quantitative polymerase chain reaction, western blotting, ELISA, and immunofluorescence analysis. The therapeutic efficacy of BMSC-exos in vivo was evaluated by hematoxylin and eosin (H&E) staining, ELISA, immunofluorescence staining, and TUNEL assays. RESULTS: BMSC-exos upregulated SIRT6 expression, promoted HMGB1 deacetylation, and prevented the nuclear-to-cytoplasmic translocation of HMGB1, thereby inhibiting activation of the HMGB1/TLR4/NF-κB signaling pathway, alleviating inflammation in IVDD, and protecting NP cells in vitro. Furthermore, BMSC-exos suppressed inflammatory responses, reduced NP cell apoptosis, and attenuated IVDD progression in vivo. CONCLUSIONS: To our knowledge, this study provides the first evidence that BMSC-exos inhibit inflammation by regulating the SIRT6/HMGB1/TLR4/NF-κB pathway, thereby attenuating IVDD progression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, 510120, China; Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, Guangdong, 510120, China; The Second Clinica…
- The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, 510120, China; Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, Guangdong, 510120, China.
- The Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, 510120, China.
- Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, Guangdong, 510120, China.
- The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, 510120, China; Guangdong Pharmaceutical University, Guangzhou, Guangdong, 510006, China.
- The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, 510120, China; Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, Guangdong, 510120, China. Electronic address…
Förderung
- Department of Science and Technology of Guangdong Province
- Department of Education of Guangdong Province
- National Natural Science Foundation of China
- China Postdoctoral Science Foundation
- Guangzhou Municipal Science and Technology Project
- Guangdong Hospital of Traditional Chinese Medicine
Zitieren
APA
Wang, H., Wen, Y., Mai, L., Li, X., Lin, Y., Xiao, Z., Li, Y., Zhang, Y., & Chen, B. (2026). Bone marrow mesenchymal stem cell-derived exosomes ameliorate intervertebral disc degeneration by regulating HMGB1 acetylation via SIRT6. Biochemical and Biophysical Research Communications, 814, 153648. https://doi.org/10.1016/j.bbrc.2026.153648
Vancouver
Wang H, Wen Y, Mai L, Li X, Lin Y, Xiao Z, et al. Bone marrow mesenchymal stem cell-derived exosomes ameliorate intervertebral disc degeneration by regulating HMGB1 acetylation via SIRT6. Biochemical and Biophysical Research Communications. 2026;814:153648. doi:10.1016/j.bbrc.2026.153648
BibTeX
@article{Wang2026,
author = {Wang, Hongshen and Wen, Yong and Mai, Laoqi and Li, Xinyi and Lin, Yongpeng and Xiao, Zhifeng and Li, Yongjin and Zhang, Yuyi and Chen, Bolai},
title = {Bone marrow mesenchymal stem cell-derived exosomes ameliorate intervertebral disc degeneration by regulating HMGB1 acetylation via SIRT6},
journal = {Biochemical and Biophysical Research Communications},
year = {2026},
volume = {814},
pages = {153648},
doi = {10.1016/j.bbrc.2026.153648}
}
EUVIMED